These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 9255390)

  • 1. p35nck5a and cyclin-dependent kinase 5 colocalize in Lewy bodies of brains with Parkinson's disease.
    Nakamura S; Kawamoto Y; Nakano S; Akiguchi I; Kimura J
    Acta Neuropathol; 1997 Aug; 94(2):153-7. PubMed ID: 9255390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclin-dependent kinase 5 (Cdk5) associated with Lewy bodies in diffuse Lewy body disease.
    Takahashi M; Iseki E; Kosaka K
    Brain Res; 2000 Apr; 862(1-2):253-6. PubMed ID: 10799694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cortical and brainstem-type Lewy bodies are immunoreactive for the cyclin-dependent kinase 5.
    Brion JP; Couck AM
    Am J Pathol; 1995 Nov; 147(5):1465-76. PubMed ID: 7485409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Developmental alteration of the expression and kinase activity of cyclin-dependent kinase 5 (Cdk5)/p35nck5a in the rat retina.
    Hirooka K; Tomizawa K; Matsui H; Tokuda M; Itano T; Hasegawa E; Wang JH; Hatase O
    J Neurochem; 1996 Dec; 67(6):2478-83. PubMed ID: 8931481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct cellular compartment of cyclin-dependent kinase 5 (Cdk5) and neuron-specific Cdk5 activator protein (p35nck5a) in the developing rat cerebellum.
    Matsushita M; Tomizawa K; Lu YF; Moriwaki A; Tokuda M; Itano T; Wang JH; Hatase O; Matsui H
    Brain Res; 1996 Sep; 734(1-2):319-22. PubMed ID: 8896840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of neurofilament proteins with neuronal Cdk5 activator.
    Qi Z; Tang D; Zhu X; Fujita DJ; Wang JH
    J Biol Chem; 1998 Jan; 273(4):2329-35. PubMed ID: 9442078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The neuronal cyclin-dependent kinase 5 activator p35Nck5a and Cdk5 activity in monocytic cells.
    Studzinski GP; Harrison JS
    Leuk Lymphoma; 2003 Feb; 44(2):235-40. PubMed ID: 12688339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. cdk5 expression and association with p35nck5a in early stages of rat cerebellum neurogenesis; tyrosine dephosphorylation and activation in post-mitotic neurons.
    Lazaro JB; Kitzmann M; Cavadore JC; Muller Y; Clos J; Fernandez A; Lamb NJ
    Neurosci Lett; 1996 Oct; 218(1):21-4. PubMed ID: 8939471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of cyclin-dependent kinase 5 (Cdk5) and neuronal Cdk5 activator in bovine brain.
    Lee KY; Rosales JL; Tang D; Wang JH
    J Biol Chem; 1996 Jan; 271(3):1538-43. PubMed ID: 8576150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclin-dependent kinase 5 in Lewy body-like inclusions in anterior horn cells of a patient with sporadic amyotrophic lateral sclerosis.
    Nakamura S; Kawamoto Y; Nakano S; Ikemoto A; Akiguchi I; Kimura J
    Neurology; 1997 Jan; 48(1):267-70. PubMed ID: 9008532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Localization and developmental changes in the neuron-specific cyclin-dependent kinase 5 activator (p35nck5a) in the rat brain.
    Tomizawa K; Matsui H; Matsushita M; Lew J; Tokuda M; Itano T; Konishi R; Wang JH; Hatase O
    Neuroscience; 1996 Sep; 74(2):519-29. PubMed ID: 8865202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unbiased Proteomics of Early Lewy Body Formation Model Implicates Active Microtubule Affinity-Regulating Kinases (MARKs) in Synucleinopathies.
    Henderson MX; Chung CH; Riddle DM; Zhang B; Gathagan RJ; Seeholzer SH; Trojanowski JQ; Lee VMY
    J Neurosci; 2017 Jun; 37(24):5870-5884. PubMed ID: 28522732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alpha-synuclein pathology in Parkinson's and Alzheimer's disease brain: incidence and topographic distribution--a pilot study.
    Jellinger KA
    Acta Neuropathol; 2003 Sep; 106(3):191-201. PubMed ID: 12845452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synphilin-1 is present in Lewy bodies in Parkinson's disease.
    Wakabayashi K; Engelender S; Yoshimoto M; Tsuji S; Ross CA; Takahashi H
    Ann Neurol; 2000 Apr; 47(4):521-3. PubMed ID: 10762166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular co-localization of phosphorylated tau- and NACP/alpha-synuclein-epitopes in lewy bodies in sporadic Parkinson's disease and in dementia with Lewy bodies.
    Arima K; Hirai S; Sunohara N; Aoto K; Izumiyama Y; Uéda K; Ikeda K; Kawai M
    Brain Res; 1999 Oct; 843(1-2):53-61. PubMed ID: 10528110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuronal cdc-2 like kinase in developing kindling rat hippocampus.
    Cai X; Tang D; Xu R
    Chin Med J (Engl); 2001 Mar; 114(3):248-52. PubMed ID: 11780307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracellular localization of cyclin-dependent kinase 5 (CDK5) in mouse neuron: CDK5 is located in both nucleus and cytoplasm.
    Ino H; Chiba T
    Brain Res; 1996 Sep; 732(1-2):179-85. PubMed ID: 8891282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extensive axonal Lewy neurites in Parkinson's disease: a novel pathological feature revealed by alpha-synuclein immunocytochemistry.
    Braak H; Sandmann-Keil D; Gai W; Braak E
    Neurosci Lett; 1999 Apr; 265(1):67-9. PubMed ID: 10327208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuronal Cdc2-like kinases: neuron-specific forms of Cdk5.
    Lee KY; QI Z; Yu YP; Wang JH
    Int J Biochem Cell Biol; 1997 Jul; 29(7):951-8. PubMed ID: 9375376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leucine-rich repeat kinase 2 is associated with the endoplasmic reticulum in dopaminergic neurons and accumulates in the core of Lewy bodies in Parkinson disease.
    Vitte J; Traver S; Maués De Paula A; Lesage S; Rovelli G; Corti O; Duyckaerts C; Brice A
    J Neuropathol Exp Neurol; 2010 Sep; 69(9):959-72. PubMed ID: 20720502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.